8 results match your criteria: "National Institute of Cardiology of Mexico[Affiliation]"

Colchicine for the Prevention of Cardiovascular Disease: Potential Global Implementation.

Curr Cardiol Rep

May 2024

Leon H. Charney Division of Cardiology and Center for the Prevention of Cardiovascular Disease, New York University Grossman School of Medicine, New York, NY, 10016, USA.

Purpose Of Review: Targeting traditional cardiovascular risk factors is effective in reducing recurrent cardiovascular events, yet the presence of residual cardiovascular risk due to underlying systemic inflammation is a largely unaddressed opportunity. This review aims to comprehensively assess the evolving role of colchicine as a therapeutic approach targeting residual inflammatory risk in the context of those with coronary artery disease (CAD).

Recent Findings: Inflammation plays a significant role in promoting atherosclerosis, and targeting anti-inflammatory pathways has the potential to decrease cardiovascular events.

View Article and Find Full Text PDF

Dengue and the heart.

Cardiovasc J Afr

January 2022

Division of Cardiology, Kingston Health Science Center, Queen's University, Kingston, Ontario, Canada. Email: Adrian.

Dengue is a neglected viral arthropod-borne tropical disease transmitted by the bite of infected spp. mosquitoes. It is responsible for a significant global burden of disease and corresponding socio-economic implications.

View Article and Find Full Text PDF

We present the case of an 18-year-old man with aborted sudden cardiac death. His initial echocardiogram suggested an anomalous origin of the left coronary artery from the pulmonary artery. Diagnosis was confirmed with coronary angiography.

View Article and Find Full Text PDF

To investigate the role of right ventricular free wall strain (RVFWSL) to predict low functional capacity in repaired tetralogy of Fallot (rTOF). We prospectively enrolled 33 patients with rTOF with moderate to severe PR who underwent rest and peak exercise echocardiography on a semisupine cycloergometer. Conventional function and strain imaging parameters of both ventricles were measured.

View Article and Find Full Text PDF

Objectives: This study sought to evaluate the potential clinical impact of using 3-dimensional echocardiography (3DE) to measure left ventricular ejection fraction (LVEF) in patients considered for implantable cardioverter-defibrillator (ICD) implantation and to assess the predictive value of 3DE LVEF for arrhythmic events.

Background: ICD therapy is currently recommended to prevent sudden cardiac death in patients with symptomatic heart failure and LVEF ≤35%, and in asymptomatic patients with ischemic heart disease and LVEF ≤30%. Two-dimensional echocardiography (2DE) is currently used to calculate LVEF.

View Article and Find Full Text PDF

The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes different types of recommendations with varying degrees of scientific evidence. In addition, the algorithm is required to be comprehensive but not too complex, informative yet simple and straightforward.

View Article and Find Full Text PDF

Atrial septal defect in adults.

Timely Top Med Cardiovasc Dis

December 2007

Adult Cardiology Department, National Institute of Cardiology of Mexico, Mexico City, Mexico.

The treatment of the atrial septal defect (ASD) in patients older than 40 years of age is controversial. We analyzed our experience according to different subgroups: i) the natural history of adults without closure of the defect; ii) comparison between surgical closure versus no closure; and iii) comparison between surgical versus transcatheter occlusion. It was concluded that surgical treatment offers better results than medical treatment alone.

View Article and Find Full Text PDF

We prospectively examined whether surgical treatment of secundum atrial septal defects (ASDs) in patients > or =40 years old improves their long-term clinical outcome. Surgical treatment of secundum ASDs in adults > 40 years old is a subject of controversy because of the perception of good long-term clinical outcomes in patients with unrepaired ASDs and the lack of data from randomized trials. We recruited 521 patients > 40 years old with secundum ASDs referred for treatment; 48 were excluded.

View Article and Find Full Text PDF